Mode
Text Size
Log in / Sign up

voglibose

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of voglibose

7 trials tracked of voglibose: 4 in phase 3 or 4.

7Trials tracked
4Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 3 Phase 2 2 Other / NA 1
  1. Phase 4 Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 Diabetes Completed
  2. Phase 3 Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan Completed
  3. Phase 3 MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104) Completed
  4. Phase 3 Japanese P III vs Voglibose and Placebo Completed
  5. Phase 2 Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan Completed
  6. Phase 2 Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan Completed
Show 1 more trials
  1. N/A Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance" Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.